论文部分内容阅读
中国中医研究院眼科医院日前在与一位双目失明的白内障患者签订了本市首例医疗手术公证协议后,为患者左眼实施了超生乳化联合人工晶体植入术。目前患者的视力已由仅存光感上升为0.30。 76岁的患者张某因白内障双目失明,同时还患有高血压、冠心病、贫血、多囊肾等多种疾病。患者的全身情况属于人工晶体植入术的手术禁忌症,此前多家医院曾经拒绝为其治疗。但患者本人求医心切,而且眼科医院的大夫在检查诊断后认为其尚存一线治疗希望。为避免医疗纠纷,病人家属与眼科医院主管医生在石景
The Chinese Academy of Ophthalmology Eye Hospital recently signed the city’s first medical surgery notary agreement with a patient with blindness in cataract, and then performed super-emulsification and intraocular lens implantation for the patient’s left eye. At present, the patient’s visual acuity has risen by only 0.30. In the 76-year-old patient, Zhang was blind due to cataract. He also suffered from various diseases such as hypertension, coronary heart disease, anemia, and polycystic kidney disease. The general condition of the patient belongs to the surgical contraindication of intraocular lens implantation, after many hospitals had refused to treat him. However, the patient himself is eager to seek medical treatment, and the doctor of the ophthalmology hospital believes that he has a first-line treatment hope after examination and diagnosis. In order to avoid medical disputes, the patient’s family members and doctors in charge of eye hospitals in Shijing